Related by context. All words. (Click for frequent words.) 74 Phenoptin 73 phase III isavuconazole 73 YONDELIS 73 Evoltra ® 72 budesonide foam 72 Raptiva R 72 balsalazide tablet 72 Peginterferon alfa 2b 72 Pivotal Phase III 72 acyclovir Lauriad R 72 SYCREST 72 Increlex R 71 FOLOTYN ® 71 SNT MC# 71 RAPTIVA 71 INSPIRE Trial Phase III 71 Golimumab 71 RhuDex 71 SUTENT ® 71 Neupro R 71 Cimzia TM 71 acetonide FA 70 Liprotamase 70 6R BH4 70 Initiate Clinical Trial 70 Phase IIIb study 70 Granted Orphan Drug 70 TEMODAL 70 MAGE A3 ASCI 70 Orphan Status 70 Noxafil 70 rilonacept 70 Zorbtive TM 70 sorafenib tablets 70 Betaferon R 70 Amrubicin 70 Fibrillex TM 70 Phase IIIb clinical 70 rasagiline tablets 70 Cimzia ® certolizumab pegol 70 dextromethorphan quinidine 70 rheumatoid arthritis psoriatic arthritis 70 etanercept Enbrel 70 Dacogen injection 70 Cellegesic 70 IL# PE#QQR 69 severe hypercholesterolemia 69 Plicera 69 levocetirizine 69 CIMZIA TM certolizumab pegol 69 MOVIPREP R 69 rotigotine transdermal patch 69 Cancidas 69 Actimmune ® 69 ORENCIA R 69 Dalbavancin 69 SPRYCEL ® 69 MYCAMINE 69 R vitespen 69 Increlex ® 69 Raptiva ® 69 Pafuramidine 69 SinuNase TM 69 Zemplar Capsules 69 Xyrem ® 69 tramiprosate Alzhemed TM 69 reslizumab 69 MAA submission 69 pregabalin Lyrica 69 hoFH 69 Alzhemed TM 69 Phase Ib IIa 69 ANTEGREN 69 Androxal TM 69 Firazyr 69 atypical Hemolytic Uremic Syndrome 69 BRILINTA 69 Soliris eculizumab 69 Zenvia ™ 69 Kepivance 69 CAELYX 69 PREOS R 69 Romiplostim 69 Lupus Nephritis 69 novel oral anticoagulant 69 rhIGF-I/rhIGFBP-3 69 ularitide 69 TBC# 69 Aflibercept 69 CDP# 69 delivers fluocinolone acetonide FA 69 PEGINTRON TM 69 Perforomist ™ Inhalation Solution 69 Pruvel 69 Gonal f 69 Cloretazine ® 69 Arcalyst 69 Retacrit 69 Oracea TM 69 Levetiracetam 69 SinuNase ™ 69 Somatuline Depot 69 alemtuzumab Campath 69 OvaRex ® MAb 69 Rebif ® 68 Receives Positive Opinion 68 pediatric Crohn disease 68 Eculizumab 68 Panzem R 68 Milnacipran 68 Alvesco R 68 Velcade bortezomib 68 lintuzumab SGN 68 Investigational Treatment 68 MPS VI 68 HQK 68 Marketing Authorisation Application 68 AMEVIVE 68 trastuzumab DM1 T DM1 68 Mycamine 68 Humira adalimumab 68 Safinamide 68 PDX pralatrexate 68 CONBRIZA 68 methylnaltrexone bromide 68 ospemifene 68 CLARITY study 68 PEG PAL 68 midstage clinical 68 Evoltra 68 mertansine 68 sunitinib malate 68 Elagolix 68 Pirfenidone 68 Fast Track Status 68 Genasense ® 68 relapsing remitting MS RRMS 68 phase IIIb 68 Saxagliptin 68 Zavesca r 68 PEG INTRON R 68 STELARA TM 68 Deferiprone 68 Preotact R 68 Allovectin 7 68 formerly LymphoStat B 68 PHX# 68 Vitrasert R 68 Somatuline R Depot 68 forodesine 68 Certican 68 Inhalation Solution 68 R sorafenib tablets 68 lexidronam injection 68 Sebivo 68 TRANSDUR Sufentanil 68 Targretin capsules 68 CEQ# 68 Dupuytren Contracture 68 Kuvan R 68 UPLYSO 68 Plenaxis TM 68 Pegloticase 68 docetaxel Taxotere R 68 Sprycel dasatinib 68 phase IIa clinical 68 Phase 2b Clinical Trial 68 Receives Orphan Drug Designation 68 Febuxostat 68 REBETOL combination therapy 68 Dual Opioid 68 Clolar ® 68 Campath ® 68 phase IIa 68 HEPLISAV TM 68 Esbriet ® 68 thalidomide Thalomid 68 constipation OIC 68 toenail onychomycosis 68 Naglazyme 68 Gabapentin GR 68 Nivestim 68 Phase III Clinical Trial 68 orally inhaled migraine 68 ALN HPN 68 VIVITROL ® 68 PDE4 inhibitor 68 alefacept 68 PRTX 68 Trobalt 68 Gamunex C 68 Vimpat ® lacosamide 68 octreotide implant 68 relapsing multiple sclerosis 68 refractory chronic lymphocytic 68 Proquin XR 68 GW# [003] 68 Ceflatonin R 68 histamine dihydrochloride 68 selective S#P# receptor agonist 67 dirucotide MBP# 67 miconazole Lauriad ® 67 myelodysplastic myeloproliferative diseases 67 Phase IIb clinical trials 67 Temsirolimus 67 BARACLUDE R 67 GVAX ® 67 GSK# [001] 67 Alinia 67 Submits NDA 67 relapsed MM 67 Archexin 67 JAK inhibitor 67 IBS C 67 alvimopan 67 pancreatic enzyme replacement 67 esophageal candidiasis 67 Remicade infliximab 67 LAF# 67 Qutenza TM 67 Arranon 67 LEVADEX ™ 67 antibody MAb 67 Proellex TM 67 Initiates Enrollment 67 Phase #b/#a clinical 67 Navelbine ® 67 Phase Ib study 67 successfully commercialize Iluvien 67 IMA# 67 ARIXTRA R 67 QNEXA ® 67 opioid induced bowel dysfunction 67 KRN# 67 Vandetanib 67 Sycrest 67 Eluting Coronary Stent System 67 Amgen Enbrel 67 investigational antiplatelet agent 67 IMiDs ® compound 67 Nexavar sorafenib 67 Proleukin 67 Meets Primary Endpoint 67 galiximab 67 refractory APL 67 COLAZAL R 67 post herpetic neuralgia PHN 67 GALNS 67 Lubiprostone 67 Besivance 67 AZILECT ® 67 Corlux 67 Fabry Disease 67 R Saizen R 67 Laquinimod 67 R lenalidomide 67 ACTEMRA TM 67 Daclizumab 67 psoriasis rheumatoid arthritis 67 ORENCIA ® 67 Completes Patient Enrollment 67 diarrhea predominant irritable 67 Diamyd ® 67 AVONEX ® 67 Mipomersen 67 docetaxel Taxotere ® 67 Ganite ® 67 Aplidin 67 Cimzia certolizumab pegol 67 Gleevec Glivec 67 Personalized Immunotherapy 67 Ozurdex 67 Rilonacept 67 randomized Phase IIb 67 interferon gamma 1b 67 MERREM 67 #I TM# 67 Iluvien ® 67 AIR CF1 67 phase IIb trial 67 CYT# potent vascular disrupting 67 Zenvia Phase III 67 KNS # 67 Orencia abatacept 67 Jevtana 67 IV Busulfex 67 sargramostim 67 beta 1a 67 cannabinor 67 Phase IIb Trial 67 Ambrisentan 67 Neurodex 67 markets HP Acthar 67 PRN FDA Approves 67 INCB# [001] 67 nasal calcitonin product 67 inhaled AAT 67 prucalopride 67 Zarnestra 67 Initiates Clinical Trial 67 Civacir 67 TYGACIL 67 Alocrest 67 Psoriasis Drug 67 RELOVAIR ™ 67 diabetic neuropathic pain 67 TASKi3 67 topically applied SEPA 67 Soriatane 67 midstage trials 67 MKC# MT 67 ACOMPLIA R 67 RSR# 67 IMiDs 67 LEUKINE 67 icatibant 67 briakinumab 67 ALVESCO R 67 Zytiga 67 FRDA 67 topically administered 67 PF # [002] 67 telomerase therapeutic 67 LibiGel ® 67 REVLIMID ® 67 Onrigin 67 Tarceva TM 67 incyclinide 67 GAMMAGARD 67 Filgrastim 67 adalimumab Humira 67 Bazedoxifene 66 REMINYL ® 66 baminercept 66 Vidaza azacitidine 66 Inhalation Aerosol 66 Fludara ® 66 Roche Xeloda 66 Vicriviroc 66 IMiDs ® 66 idursulfase 66 Traficet EN 66 oxymorphone ER 66 Pyridorin 66 UCB Cimzia 66 ankylosing spondylitis psoriatic arthritis 66 ILUVIEN ® 66 Fx #A 66 IV acetaminophen 66 Bayer Onyx 66 RANK Ligand inhibitor 66 oropharyngeal candidiasis OPC 66 Cloretazine 66 vapreotide acetate 66 vinorelbine tartrate 66 methylnaltrexone 66 ONGLYZA ™ 66 albinterferon alfa 2b 66 blinded randomized placebo controlled 66 TELINTRA 66 Lambert Eaton Myasthenic 66 efalizumab 66 sitaxsentan 66 Troxatyl 66 paliperidone palmitate 66 visilizumab 66 Kuvan TM sapropterin 66 Degarelix 66 Polyphenon ® E 66 Bendamustine 66 SUPPRELIN R LA 66 Initiates Phase III 66 DepoDur 66 oxaliplatin Eloxatin 66 Diabetic Macular Edema 66 BENLYSTA ® 66 CINQUIL 66 Xcytrin R 66 Neulasta R 66 granulated mesalamine 66 Combination REOLYSIN R 66 M# rationally 66 clevidipine 66 QNEXA 66 Interferon beta 1a 66 PD LID 66 Specifid 66 Zavesca 66 Telavancin 66 Hycamtin 66 PENTASA 66 ATL# [001] 66 rALLy clinical trial 66 Pemetrexed 66 octreotide acetate 66 Glybera 66 albiglutide 66 canakinumab 66 Phase IIIb 66 Phase III Pivotal 66 Novolimus 66 Vernakalant 66 Tramiprosate ALZHEMED TM 66 INS# [001] 66 patientswith 66 Syndrome LEMS 66 LIALDA 66 omacetaxine mepesuccinate 66 Equetro 66 catheter occlusion 66 guanfacine extended release 66 highly purified pasteurized 66 Nexavar ® 66 THALOMID 66 Iluvien TM 66 neratinib 66 darbepoetin alfa Aranesp 66 Sapacitabine 66 induced macular edema 66 DNAwithPap TM Test 66 oral prodrug 66 Anturol TM 66 Saforis 66 OMNARIS Nasal Spray 66 topical gel formulation 66 candidates Dyloject TM 66 CTAP# Capsules 66 OMAPRO ™ 66 Panzem R NCD 66 Ixempra 66 phase IIb clinical 66 DPP4 inhibitor 66 teriflunomide 66 pain palliation 66 multicenter Phase II 66 thetreatment 66 Aviptadil 66 BAY #-# 66 Pivotal Trial 66 RoACTEMRA 66 INTEGRILIN R eptifibatide Injection 66 Yondelis ® 66 OHR/AVR# 66 Arzerra TM 66 PORxin TM platforms 66 molecular imaging radiopharmaceutical 66 de novo kidney transplant 66 Keppra XR 66 Catena ® 66 Certolizumab pegol 66 EGS# 66 topical calcineurin inhibitors 66 Tykerb lapatinib 66 ZOLINZA 66 oral methylnaltrexone 66 COMFORT II 66 NeuroSTAT ® 66 Tibotec Therapeutics division 66 TREDAPTIVE 66 Somatuline R Autogel R 66 CAMPATH 66 Initiates Clinical 66 GATTEX ™ 66 hyaluronidase enzyme 66 Eloxatin ® 66 ezogabine 66 adult chronic ITP 66 AZILECT R 66 Ophena TM 66 Femara letrozole 66 BRIM2 66 Serdolect ® 66 Phase IIa trial 66 AFREZZA TM 66 GERD migraine headaches 66 Expanded Indication 66 liver resection surgeries 66 panitumumab Vectibix 66 bazedoxifene 66 Prosaptide 66 Friedreich Ataxia FRDA 66 AMPYRA ® 66 IV APAP 66 tigecycline 66 volociximab 66 Triapine 66 ZACTIMA 66 Metastatic Melanoma 66 Eraxis 66 Systemic Sclerosis 66 herpetic keratitis 66 Carbamazepine 66 Auxilium Pharma 66 Soliris TM eculizumab 66 pseudobulbar affect PBA 66 oropharyngeal candidiasis 66 metastatic hormone refractory 66 Icatibant 66 pioglitazone hydrochloride 66 Desvenlafaxine 66 Capesaris 66 POSIDUR TM 66 Cetrorelix 66 Glufosfamide 66 oncolytic virus therapies 66 Amgen Neulasta R 66 Reminyl galantamine 66 alvespimycin 66 Tasigna nilotinib 66 Cethrin R 66 intranasal formulation 66 HuMax EGFr 66 Solzira ™ 66 TRANSDUR Bupivacaine 65 HuMax CD4 65 Receives Orphan Drug 65 lucinactant 65 Pfizer Camptosar 65 evaluating mipomersen 65 memantine HCl 65 Phase IIb Clinical Trial 65 Adalimumab 65 lenalidomide Revlimid R 65 Phase III Clinical Trials 65 everolimus tablets 65 tasocitinib 65 Dyloject TM 65 Rescula 65 ALN PCS 65 nucleotide analogue 65 ALVESCO ® 65 Diabetic Macular Edema DME 65 registrational 65 Eliquis 65 DEB# 65 REGN# 65 eltrombopag 65 Tasimelteon 65 Cx# [002] 65 Altastaph 65 lomitapide 65 Surfaxin LS 65 neurogenic orthostatic hypotension 65 AzaSite TM 65 placebo controlled Phase III 65 BiovaxID TM 65 Annamycin 65 Metformin GR 65 olanzapine LAI 65 Ereska 65 LymphoStat B TM 65 Aurexis 65 MabThera Rituxan 65 Initiates Phase II 65 TKM ApoB 65 Rhucin R 65 Microplasmin 65 Removab 65 RhuDex TM 65 sJIA 65 Evoltra R 65 Immunotherapeutic 65 Myocet 65 dose escalation clinical 65 selective estrogen receptor modulator 65 Rebif interferon beta 1a 65 Plenaxis R 65 aripiprazole Abilify 65 Ozarelix 65 Behcet uveitis 65 relapsed refractory multiple myeloma 65 Toremifene 65 ThermoDox R 65 DIFICID ™ 65 NDA Submission 65 hyperphenylalaninemia HPA due 65 subcutaneous formulation 65 BYETTA ® 65 nalbuphine ER 65 Xelox 65 TACI Ig 65 sapropterin dihydrochloride 65 Benlysta belimumab 65 IMiDs R 65 BENLYSTA TM 65 Sanctura XR 65 OROS R Hydromorphone 65 liprotamase 65 Patients Treated With 65 Entereg R 65 LEVADEX TM 65 REVLIMID R 65 rALLy 65 MAXY alpha 65 SNT-MC#/idebenone 65 Hyphanox 65 equine osteoarthritis 65 FDA Approvals 65 Pegasys peginterferon alfa 2a 65 Tesetaxel 65 MKC# 65 Hsp# Inhibitor 65 IONSYS TM 65 Aceon 65 Taxotere docetaxel 65 Orapred ODT 65 Phase Ib II 65 basiliximab 65 receptor tyrosine kinase inhibitor 65 MyVax R 65 Motavizumab 65 REYATAZ R 65 Phase 1a clinical 65 Investigational Compound 65 Genentech Rituxan 65 inhalation powder 65 Crofelemer budesonide foam 65 FIRMAGON R 65 TASKi2 65 DDP# 65 Phase III Trials 65 CIMZIA R 65 HCV Protease Inhibitor 65 Etanercept 65 ARCALYST ® 65 opioid induced constipation OIC 65 Lialda 65 oral renin inhibitor 65 quinolone antibiotic 65 refractory gout 65 Triolex 65 Phase III Trial 65 Phase Ib clinical 65 CALGB # [002] 65 PROMACTA 65 hypereosinophilic syndrome 65 dasatinib Sprycel ® 65 NP2 Enkephalin 65 Factor VIIa 65 PDE# inhibitors 65 salmeterol fluticasone 65 ELACYT 65 Onbrez Breezhaler 65 Pancreas Cancer Vaccine 65 dasatinib Sprycel 65 Nexavar prescribing 65 Tekamlo 65 Bayer Nexavar 65 CANCIDAS 65 Nipent R 65 ORADUR ® 65 Tofacitinib 65 Copegus ribavirin 65 sublingual tablets 65 intravenous acetaminophen 65 STELARA ™ 65 Phase 2b trial 65 MKC# MKC# PP 65 BCR ABL inhibitor 65 Aztreonam Lysine 65 PEG SN# 65 Rotigotine 65 mGluR5 NAM 65 PrevOnco 65 Pivotal Phase 65 ABILIFY ® 65 INVANZ 65 PENNSAID 65 vismodegib 65 Tracleer ® bosentan 65 SEBIVO 65 Marketing Authorisation Application MAA 65 Ocrelizumab 65 Basilea Toctino R 65 IRESSA 65 Vidaza R 65 fostamatinib 65 phase Ib 65 E1 INT TM 65 glatiramer 65 LUMINATE 65 Mepact 65 Long Term Efficacy 65 ONTAK 65 YONDELIS R 65 Prulifloxacin 65 sorafenib Nexavar 65 Navelbine R 65 oral iron chelator 65 Cethrin 65 TheraCIM 65 adefovir dipivoxil 65 casopitant 65 novel histone deacetylase 65 Zenpep 65 Omnitarg 65 ROTATEQ 65 Alequel 65 rufinamide 65 Tipranavir 65 Silenor ® 65 ruxolitinib 65 Zavesca R 65 Eli Lilly Cymbalta 65 R#/MEM # 65 atypical antipsychotic medication 65 Receives Approvable Letter 65 Simponi golimumab 65 cinacalcet HCl 65 Tezampanel 65 inhalation aerosol 65 sNDAs 65 Fingolimod 65 Entereg TM 65 Levoleucovorin 65 HP Acthar Gel repository 65 HCD# [002] 65 Zemplar 65 EVIZON ™ 65 Celgene Revlimid 65 Silodosin 65 Multaq dronedarone 65 VISICOL R 65 Asmanex 65 Joulferon 65 ® lenalidomide 65 CB2 selective receptor agonist 65 Cinryze ™ 65 Inhalation Powder 65 desvenlafaxine 65 Aphthasol R 65 compound INCB# 65 systemic juvenile idiopathic 65 BIM #A# 65 RhuDex ® 65 Fodosine 65 eosinophilic asthma 65 Quinamed 65 golimumab CNTO 65 Pazopanib 65 Amgen Neulasta ® 65 epoetin alpha 65 AstraZeneca Symbicort 65 APTIVUS 65 psoriasis Crohn disease 65 mitoxantrone plus 65 investigational monoclonal antibody 65 Virulizin ® 65 Phase #/#a 65 OncoGel 65 ALN VSP Phase 65 oxypurinol 65 NAVISTAR R 65 Tyzeka 65 5 lipoxygenase inhibitor 65 HeFH 65 pioglitazone HCl 65 FIRAZYR 65 FDA APPROVES 65 GATTEX TM 65 Tolvaptan 65 Telzir 65 phase IIb study 65 cetuximab Erbitux R 65 oral talactoferrin 65 Increlex TM 65 Successfully Completes Phase 65 Interferon beta 1b 65 neovascular diseases 65 serotonin norepinephrine reuptake inhibitor 65 MetroGel 65 Xolegel 65 nilotinib Tasigna 65 Glatiramer Acetate 65 overactive bladder syndrome 65 Dementia Related Psychosis 65 tiapamil 65 use transdermal sumatriptan 65 relapsed leukemia 65 ALN TTR# 65 BLP# Liposome Vaccine 65 Brentuximab Vedotin SGN 65 glucokinase activator 65 Ecallantide 65 ZEVALIN ® 65 dalbavancin 65 Receives Fast Track 65 Bosutinib 65 Onalta ™ 65 Sodium oxybate 65 RezularTM 65 XYZAL R 65 Medidur ™ FA 65 Danazol 64 Chemophase 64 vosaroxin 64 CINTREDEKIN BESUDOTOX 64 immunotherapeutic vaccine 64 QVAR 64 pralatrexate injection folate analogue 64 biologic therapy 64 Azmacort R 64 Submits Response 64 ELADUR ™ 64 EnzymeRx 64 Phase III multicenter 64 SYN# 64 Syncria R 64 Pegintron 64 Zelrix 64 synthetic retinoid 64 evaluating tivozanib 64 Mirapexin 64 chronic idiopathic thrombocytopenic purpura 64 Xeloda ® 64 HUMIRA adalimumab 64 ZEFTERA TM Zevtera TM 64 FavId 64 Vimpat R 64 sitaxsentan sodium 64 urocortin 2 64 Myelodysplastic Syndrome MDS 64 Tredaptive 64 Veronate R 64 Canvaxin 64 Pimavanserin 64 Zingo TM 64 chronic ITP patients 64 Panzem ® 64 Orphan designation 64 Orphan Designation 64 Keppra ® levetiracetam 64 FASLODEX 64 ACZ# 64 CRLX# 64 Starlix 64 DepoCyt 64 Asentar 64 pharmacokinetic PK study 64 personalized cellular immunotherapy 64 XIAFLEX ™ 64 Simulect 64 refractory cutaneous T 64 forodesine hydrochloride 64 KIACTA ™ 64 Brilique 64 ITAX 64 FOR FURTHER INFORMATION ABOUT 64 Receives Marketing Authorization 64 VIAject R 64 Onalta 64 intravitreal insert 64 ISTODAX ® 64 Azilect R 64 humanized therapeutic 64 Argatroban 64 Cleviprex TM clevidipine 64 L BLP# 64 Natalizumab 64 immunotherapeutic agent 64 liposome injection 64 recurrent glioblastoma multiforme 64 JZP 64 Loramyc R 64 investigational humanized monoclonal antibody 64 Ventavis 64 CR# vcMMAE 64 anthracyclines taxanes 64 Enzyme Replacement Therapy 64 G#DT 64 RoActemra 64 CRMD# 64 Vertex hepatitis C 64 Cimzia ® 64 terlipressin 64 Phase 2b Trial 64 Romidepsin 64 cutaneous T 64 r hGH 64 Spiegelmer ® 64 Azilect ® 64 ATryn ® 64 CIMZIA ™ 64 Temodar ® 64 FDA Accepts 64 BR.# 64 BioNumerik 64 Roflumilast 64 orally administered inhibitor 64 Phase 2b kidney transplant 64 BARACLUDE ® 64 Neo Bladder Augment 64 paclitaxel Taxol R 64 Kit CD# positive 64 VIAtab TM 64 Glatiramer acetate 64 PEGylated interferon beta 1a 64 Actemra tocilizumab 64 eslicarbazepine acetate 64 Paliperidone Palmitate 64 Prestara 64 Preotact 64 RESOLOR 64 novel VDA molecule 64 Ciclesonide 64 TLK# 64 pomalidomide 64 ENTEREG ® 64 malignant ascites 64 confirmatory Phase III 64 LUCENTIS 64 bicifadine 64 topical NSAID 64 ARCOXIA 64 oral picoplatin 64 PNP inhibitor 64 Acute Attacks 64 agalsidase alfa 64 CUSTOM III 64 RAPAMUNE 64 multicenter multinational 64 StaphVAX R 64 Fibrin Pad 64 R bendamustine hydrochloride 64 Frova ® 64 compound KOS 64 pegylated interferons 64 tramiprosate ALZHEMED TM 64 metaglidasen 64 JAK Inhibitor 64 leukotriene receptor antagonist 64 Kuvan 64 sevelamer carbonate 64 Tracleer R 64 eprodisate Fibrillex TM 64 PGL# 64 Oracea R 64 investigational pharmacologically unique 64 HoFH 64 LymphoStat B belimumab 64 Initiated Phase 64 dyskinesia PD LID 64 Granulocyte Colony Stimulating Factor 64 orBec 64 Cimzia R 64 BYDUREON ™ 64 Perforomist TM Inhalation Solution 64 dopamine partial agonist 64 POSIDUR ™ 64 Warfarin Coumadin 64 Phase #b/#a 64 Achieves Primary Endpoint 64 omega interferon 64 Gralise 64 MGN# 64 BEMA Buprenorphine 64 thorough QT 64 Oral Spray 64 www.soliris.net 64 sapacitabine CYC# 64 Atelvia 64 dual endothelin receptor antagonist 64 Demonstrates Positive 64 HFA MDI 64 invasive candidiasis 64 zileuton IV 64 Vectibix panitumumab 64 APEX PD 64 Azedra 64 CIMZIA r 64 Adjunctive Therapy 64 NICE Recommends 64 Medidur TM FA 64 Savella ® 64 riociguat 64 oral salmon calcitonin 64 liposomal formulation 64 Kineret R 64 treat chronic sinusitis 64 Belimumab 64 budesonide inhalation suspension 64 FDA Orphan Drug 64 injectable formulations 64 Onco TCS 64 orphan medicinal product 64 phase IIb III 64 migraine prophylaxis 64 Systemic Juvenile Idiopathic 64 EDEMA3 64 cell lymphoma CTCL 64 R#/MEM 64 Clonicel 64 BrachySil TM 64 Junovan 64 ketoprofen patch 64 Cimzia 64 Mycophenolate Mofetil 64 elotuzumab 64 Denufosol